Linden Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IRDMB
Iridium Communications Inc - 6.75% Series B
IRDMB
|
+$8.95M |
| 2 |
RH
RH
|
+$4.41M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$4.13M |
| 4 |
JOBS
51job Inc
JOBS
|
+$2.27M |
| 5 |
Palo Alto Networks
PANW
|
+$798K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Encore Capital Group
ECPG
|
+$7.41M |
| 2 |
ALR.PRB
Alere Inc
ALR.PRB
|
+$6.83M |
| 3 |
QGENF
QIAGEN NV
QGENF
|
+$4.59M |
| 4 |
Herbalife
HLF
|
+$2.49M |
| 5 |
MCP
MOLYCORP INC COM STK
MCP
|
+$1.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 1.98% |
| 2 | Consumer Discretionary | 1.68% |
| 3 | Industrials | 1.1% |
| 4 | Consumer Staples | 0.98% |
| 5 | Healthcare | 0.43% |
Similar funds
Linden Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, Linden Advisors held 54 positions worth $458M, up 17% from $391M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Linden Advisors withdrew a net $86.3M in Q2 2014, closing 5 positions and reducing 4 holdings. Its most notable exit was Encore Capital Group, an estimated $7.41M position sold in full.
By sector, the portfolio is most concentrated in Materials at 2% of assets, down from 4.7% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Linden Advisors opened a new position in Iridium Communications Inc - 6.75% Series B worth $9.33M.
- Linden Advisors's largest Q2 2014 buy was Iridium Communications Inc - 6.75% Series B: 28,000 shares worth $9.33M.
- Linden Advisors added most to PDL BioPharma, Inc. in Q2 2014, an estimated $553K increase.
- Linden Advisors's biggest Q2 2014 reduction was Alere Inc, cutting an estimated $6.83M.
- Linden Advisors fully exited Encore Capital Group in Q2 2014, selling an estimated $7.41M.
- Linden Advisors's ten largest holdings make up 59% of its $458M portfolio in Q2 2014.
- Linden Advisors opened 9 new positions and closed 5 in Q2 2014.
- Linden Advisors's portfolio value rose 17% quarter-over-quarter to $458M.
Based on Linden Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.